Managing Menopausal Symptoms: Common Questions and Answers

被引:0
作者
Chang, Jennifer G. [1 ,3 ]
Lewis, Meghan N. [2 ]
Wertz, Maggie C. [1 ]
机构
[1] Eglin Family Med Residency, Eglin AFB, FL USA
[2] Malcolm Grow Med Clin, Joint Base Andrews, MD USA
[3] Eglin Family Med Residency, 307 Boatner Rd, Eglin AFB, FL 32542 USA
关键词
HORMONE-THERAPY; VASOMOTOR SYMPTOMS; POSTMENOPAUSAL WOMEN; HOT FLASHES; MANAGEMENT; EFFICACY; MORTALITY; ESTROGEN; PLACEBO; CANCER;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Menopausal symptoms are widespread and significantly impact quality of life. Common symptoms of menopause are vasomotor (i.e., hot flashes and night sweats) and genitourinary (e.g., vulvovaginal irritation and dryness, dyspareunia, urinary problems), although women may also experience changes in sexual function, mood, and sleep. Estrogen -containing hormone therapy is effective treatment for vasomotor symptoms. Nonhormonal medications for vasomotor symptoms include selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and gabapentin. Selective serotonin reuptake inhibitors should not be administered to women taking tamoxifen. Cognitive behavior therapy and clinical hypnosis are effective for short-term reduction of vasomotor symptoms and associated sleep disturbances, but data are lacking to support the effectiveness of other nonpharmacologic treatments such as herbal or botanical supplements, exercise, and acupuncture. Hormone -free vaginal moisturizers are noninferior to estrogen -based therapies for treating genitourinary syndrome of menopause. Other treatment options for vaginal dryness and dyspareunia associated with menopause include ospemifene and intravaginal dehydroepiandrosterone. Management of menopausal symptoms should involve shared decision -making that is informed by the best available evidence and individual risks and preferences.
引用
收藏
页码:28 / 39
页数:12
相关论文
共 51 条
  • [1] The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society
    不详
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (09): : 976 - 992
  • [2] Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial
    Archer, David F.
    Goldstein, Steven R.
    Simon, James A.
    Waldbaum, Arthur S.
    Sussman, Steven A.
    Altomare, Corrado
    Zhu, Julie
    Yoshida, Yuki
    Schaffer, Sam
    Soulban, Graziella
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (06): : 611 - 621
  • [3] Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition
    Avis, Nancy E.
    Crawford, Sybil L.
    Greendale, Gail
    Bromberger, Joyce T.
    Everson-Rose, Susan A.
    Gold, Ellen B.
    Hess, Rachel
    Joffe, Hadine
    Kravitz, Howard M.
    Tepper, Ping G.
    Thurston, Rebecca C.
    [J]. JAMA INTERNAL MEDICINE, 2015, 175 (04) : 531 - 539
  • [4] Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study
    Busby, John
    Mills, Ken
    Zhang, Shu-Dong
    Liberante, Fabio Giuseppe
    Cardwell, Chris R.
    [J]. BREAST CANCER RESEARCH, 2018, 20
  • [5] Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society
    Carpenter, Janet
    Gass, Margery L. S.
    Maki, Pauline M.
    Newton, Katherine M.
    Pinkerton, JoAnn V.
    Taylor, Maida
    Utian, Wulf H.
    Schnatz, Peter F.
    Kaunitz, Andrew M.
    Shapiro, Marla
    Shifren, Jan L.
    Hodis, Howard N.
    Kingsberg, Sheryl A.
    Liu, James H.
    Richard-Davis, Gloria
    Santoro, Nanette
    Sievert, Lynnette Leidy
    Schiff, Isaac
    Pike, Caitlin
    Allen, Penny
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (11): : 1155 - 1174
  • [6] Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms - an update on the evidence
    Castelo-Branco, C.
    Gambacciani, M.
    Cano, A.
    Minkin, M. J.
    Rachon, D.
    Ruan, X.
    Beer, A. -M.
    Schnitker, J.
    Henneicke-von Zepelin, H. -H.
    Pickartz, S.
    [J]. CLIMACTERIC, 2021, 24 (02) : 109 - 119
  • [7] Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials
    Chlebowski, Rowan T.
    Anderson, Garnet L.
    Aragaki, Aaron K.
    Manson, JoAnn E.
    Stefanick, Marcia L.
    Pan, Kathy
    Barrington, Wendy
    Kuller, Lewis H.
    Simon, Michael S.
    Lane, Dorothy
    Johnson, Karen C.
    Rohan, Thomas E.
    Gass, Margery L. S.
    Cauley, Jane A.
    Paskett, Electra D.
    Sattari, Maryam
    Prentice, Ross L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (04): : 369 - 380
  • [8] Cutson TM, 2000, AM FAM PHYSICIAN, V61, P1391
  • [9] A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms
    David, Paru S.
    Smith, Taryn L.
    Nordhues, Hannah C.
    Kling, Juliana M.
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2022, 14 : 353 - 361
  • [10] Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study
    de Arriba, Susana Garcia
    Gruentkemeier, Lisa
    Haeuser, Manuel
    May, Theodor W.
    Masur, Clarissa
    Stute, Petra
    [J]. PLOS ONE, 2022, 17 (05):